March 18, 2015
By Riley McDermid, BioSpace.com Breaking News Sr. Editor
Pennsylvania pharmaceutical company KVK Technologies will be adding 350 new jobs in Falls Township, Pa., as part of a massive new plant recently approved to be built on Cabot Boulevard, the Bucks County Courier Times reported Wednesday.
City supervisors on Tuesday night unanimously approved preliminary and final land development plans for KVK’s new 8,500-square-foot plant, as well as a second structure to be built on the same site. The first phase will add 200 jobs, while the second building will add another 150 manufacturing, technical and scientific jobs, said the company.
The company was founded in 2003 and is based in Newtown, Pa.
KVK-TECH, Inc. develops, manufactures, and markets specialty pharmaceuticals. It offers hydroxyzine, promethazine, chlorpheniramine maleate ER, phentermine, betaxolol, indomethacin SR, diethylpropion, kalexate, benzphetamine, phendimetrazine and cyclobenzaprine products.
The company offers its products in the form of immediate and modified release tablets, capsules, liquids, suspensions, solutions, powders, and semisolids. It sells its products through pharmaceutical wholesalers, distributors, chain drug stores, independent retail pharmacies, and managed care organizations in the United States.
BioSpace Temperature Poll
After Amgen Inc. said last week that it will close its South San Francisco facility acquired during its $10 billion buyout of Onyx Pharmaceuticals and will lay off 300 of Oynx’s 750 workers, BioSpace is wondering—will the number of mergers and acquisitions completed in 2014 mean a “streamlining” of biotech jobs in the Bay Area? Tell us your thoughts.
